Nationwide Trends in Opioid Consumption in Costa Rica, 2017–2024: Implications for Regulatory Policy and Public Health
Pharmacoepidemiology and Drug Safety · 2026-07 · 35 (7)
DOI: 10.1002/pds.70421 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 28.06.2026. Verfasst von Esteban Zavaleta-Monestel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Health Research Department, Clínica Bíblica, San José, Costa Rica. Hauptthemen laut MEDLINE: Analgesics, Opioid, Public Health, Drug and Narcotic Control, Practice Patterns, Physicians'. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
The global opioid crisis has highlighted substantial differences in prescribing, monitoring, and regulatory practices across health systems. In Costa Rica, comprehensive national data on opioid use have been limited. This study aimed to describe temporal trends in legally prescribed opioid consumption between 2017 and 2024 using nationwide administrative data.
Methods
A nationwide, retrospective, population‐based analysis was conducted using data from the Costa Rican Ministry of Health's narcotics registry. Dispensation records for morphine, methadone, fentanyl, oxycodone, and tapentadol were included. Opioid consumption was standardized to Morphine Milligram Equivalents (MME) using NIH HEAL conversion factors. Temporal trends were assessed using descriptive statistics and simple linear regression.
Results
A total of 31.9 million opioid dispensations were recorded during the study period. National opioid consumption peaked in 2018 (395.1 million MME), followed by an approximate 70% decline through 2023 and a modest increase in 2024. Consumption of morphine and methadone declined substantially (−72.2% and −82.4%, respectively), while oxycodone and tapentadol showed moderate increases over time. These findings indicate a marked reduction in overall opioid consumption alongside changes in the distribution of use across opioid agents.
Conclusions
Between 2017 and 2024, Costa Rica experienced a sustained decline in total opioid dispensing and a redistribution of opioid use across substances. These trends occurred in the context of strengthened regulatory oversight and expanded digital monitoring of controlled substances. While causal relationships cannot be established, the findings provide relevant population‐level evidence to support opioid stewardship and inform regulatory and public health strategies in middle‐income health systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Health Research Department, Clínica Bíblica, San José, Costa Rica.
- Pharmacy Department, Clínica Bíblica, San José, Costa Rica.
- Department of Critical Care Medicine, Clínica Bíblica, San José, Costa Rica.
- Anesthesiology and Pain Clinic Service, Clínica Bíblica, San José, Costa Rica.
ORCID-Profile: Esteban Zavaleta-Monestel, Sebastián Arguedas-Chacón, Jeaustin Mora-Jiménez, Roberto Rodríguez-Miranda
Zitieren
APA
Zavaleta-Monestel, E., Arguedas-Chacón, S., Mora-Jiménez, J., Wu-Chin, C., & Rodríguez-Miranda, R. (2026). Nationwide Trends in Opioid Consumption in Costa Rica, 2017–2024: Implications for Regulatory Policy and Public Health. Pharmacoepidemiology and Drug Safety, 35(7). https://doi.org/10.1002/pds.70421
Vancouver
Zavaleta-Monestel E, Arguedas-Chacón S, Mora-Jiménez J, Wu-Chin C, Rodríguez-Miranda R. Nationwide Trends in Opioid Consumption in Costa Rica, 2017–2024: Implications for Regulatory Policy and Public Health. Pharmacoepidemiology and Drug Safety. 2026;35(7). doi:10.1002/pds.70421
BibTeX
@article{ZavaletaMonestel2026,
author = {Zavaleta-Monestel, Esteban and Arguedas-Chacón, Sebastián and Mora-Jiménez, Jeaustin and Wu-Chin, Carlos and Rodríguez-Miranda, Roberto},
title = {Nationwide Trends in Opioid Consumption in Costa Rica, 2017–2024: Implications for Regulatory Policy and Public Health},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2026},
volume = {35},
number = {7},
doi = {10.1002/pds.70421}
}
EUVIMED